The phrase “male menopause” appears in headlines whenever a magazine wants to discuss the changes men face in midlife. It is a catchy label, but it is not a medical diagnosis. The more accurate framing is andropause — increasingly described by clinicians as age-related testosterone decline or late-onset hypogonadism — and it refers to the gradual fall in testosterone and the cluster of symptoms that some men experience beginning in their 40s and 50s. Unlike female menopause, which is a defined reproductive event with a universal and relatively abrupt hormone withdrawal, andropause is neither universal nor a clean syndrome. Some men sail through their 60s and 70s with normal hormones and few symptoms; others develop progressive fatigue, sexual dysfunction, and mood changes that meaningfully affect quality of life. The distinction matters, because how you name the problem shapes whether you treat it wisely or reach for a prescription you may not need.
Why “Andropause” Is a Contested Term
It is worth being precise about language, because the popular term oversells the biology. Female menopause involves a comparatively sharp, near-universal drop in ovarian estrogen that essentially every woman experiences by her mid-50s. Nothing equivalent happens in men. Male testosterone declines slowly and partially, the rate varies enormously between individuals, and most men keep their levels within the normal reference range for life. So when a headline equates “andropause” with “menopause,” it implies a shared, inevitable event that does not exist. Many clinicians avoid the word entirely and prefer late-onset hypogonadism — a diagnosis that has to be confirmed, not assumed from age and vague symptoms. Treat “andropause” and “male menopause” as everyday shorthand for a real but variable phenomenon, and remember that the shorthand is not itself a diagnosis you can act on.
What Andropause Actually Is
Total testosterone falls on the order of 1 to 2% per year after about age 30 in most men. By age 70, average levels are meaningfully lower than at age 25 — often in the range of 30 to 50% lower — though the figures are averages that hide wide individual variation. Free (bioavailable) testosterone tends to decline more steeply because sex hormone-binding globulin (SHBG) rises with age, reducing the fraction that is biologically active. Large longitudinal studies such as the Massachusetts Male Aging Study established these general patterns and, importantly, showed that the rate of decline differs greatly from one man to the next.
Andropause is not a synonym for “low testosterone” on a single lab report. It refers to the age-related decline accompanied by characteristic symptoms — what the Endocrine Society formally calls late-onset hypogonadism (LOH). A diagnosis requires both biochemical confirmation (serum testosterone consistently below the laboratory reference range on morning testing) and a relevant symptom cluster, particularly sexual symptoms. One number on one day is not enough.
How It Differs From Female Menopause
The differences are significant and worth restating. Female menopause is a discrete event — cessation of menstruation, near-complete ovarian estrogen withdrawal, loss of fertility — that occurs in essentially all women by about age 55. Male hormonal aging is gradual, partial, and incomplete. Many men remain biologically fertile into their 70s and 80s. Most men retain testosterone levels within the normal range throughout life, with only a subset dropping below the thresholds that would prompt consideration of treatment.
The popular media equivalence is therefore misleading. “Andropause” in the lay sense often describes a constellation of midlife symptoms that may have nothing to do with hormones — career stress, relationship transitions, weight gain, deconditioning, poor sleep, or untreated sleep apnea — and that frequently respond better to lifestyle changes than to testosterone. Assuming your symptoms are hormonal before anything is measured is the most common mistake in this area.
Symptoms
The symptom cluster that suggests genuine LOH includes reduced libido, erectile dysfunction, fewer morning erections, fatigue and reduced energy, depressed or flat mood, decreased exercise capacity, increased abdominal fat, decreased muscle mass and strength, decreased bone density, hot flashes (uncommon but real), breast tenderness or gynecomastia, and reduced cognitive sharpness or concentration. Sexual symptoms are the most specific indicators. The American Urological Association (AUA) emphasizes that nonspecific complaints alone — fatigue or low mood without any sexual symptoms — are unlikely to be caused by low testosterone and usually point elsewhere.
Many of these symptoms overlap with other conditions: depression, hypothyroidism, sleep apnea, anemia, chronic fatigue from overwork, heavy alcohol use, and metabolic syndrome. Sorting out which contributors actually apply requires a structured workup rather than an empiric trial of testosterone.
What Causes Late-Onset Hypogonadism
The decline is partly intrinsic — testicular Leydig cell function decreases with age, the hypothalamic-pituitary axis becomes less responsive, and SHBG rises. Acquired and often reversible contributors are equally important, and this is where the good news lies. Obesity is the single largest modifiable cause: visceral fat contains aromatase, which converts testosterone to estradiol and suppresses the hormonal axis. Type 2 diabetes, metabolic syndrome, untreated obstructive sleep apnea, chronic opioid use, heavy alcohol use, and certain medications (glucocorticoids, some antifungals) all contribute.
Distinguishing reversible “functional” hypogonadism from intrinsic (organic) testicular failure matters because the treatment differs. See the hypogonadism guide for the full classification, and note that functional cases are often best addressed by treating the underlying cause rather than by adding hormones.
How Andropause Is Diagnosed
The workup follows the same algorithm used for any suspected low testosterone. A focused history covers sexual function, energy, mood, sleep, weight changes, and alcohol and substance use. Two separate morning total testosterone measurements (drawn between roughly 7 and 10 a.m., when levels peak) are used to confirm a genuine lab abnormality, with free testosterone added when SHBG is suspected to be high or borderline. Additional labs typically include LH, FSH, prolactin, TSH, a complete blood count, fasting glucose or HbA1c, a lipid panel, and PSA where age-appropriate.
The Mayo Clinic stresses that age alone is not a diagnosis — many men with classic “andropause” symptoms have normal testosterone, and the symptoms turn out to be from depression, sleep apnea, medication side effects, or another treatable condition. A single low reading, particularly one drawn in the afternoon or during an acute illness, should never anchor a lifelong treatment decision.
Treatment Options
For men with reversible contributors, lifestyle modification is the highest-yield first step and carries benefits far beyond hormones. Losing roughly 10% of body weight can raise testosterone appreciably. Treating sleep apnea with CPAP often improves energy and morning erections. Reducing alcohol intake, optimizing glucose control, and beginning resistance training all measurably improve testosterone in middle-aged men, and they also lower cardiovascular and metabolic risk. Because these steps address the root cause, they are the right starting point for most functional cases.
For men whose biochemical hypogonadism persists after lifestyle correction, or whose symptoms are severe, testosterone replacement therapy (TRT) is the standard pharmacologic option — but it is a prescriber-supervised, monitored treatment, not a supplement you self-manage. The decision weighs benefit against risk, particularly fertility goals (TRT suppresses the body’s own sperm production), the need for red-blood-cell and PSA monitoring, and prostate and cardiovascular considerations covered in our TRT side effects and risks guide. Clomiphene, hCG, and aromatase inhibitors are alternatives that can preserve fertility for men who want to keep natural sperm production. Testosterone is not an anti-aging tonic, and reputable clinicians do not market it that way.
Treating coexisting depression, anxiety, and chronic insomnia is appropriate and often improves symptoms regardless of testosterone level. Cognitive and energy complaints are commonly multifactorial; mental-health support and sleep optimization matter more than they usually get credit for.
What the 2025 FDA Labeling Changes Mean
In early 2025 the FDA issued class-wide labeling changes for all testosterone products. Two points are worth knowing. First, the FDA removed the boxed-warning language about an increased risk of adverse cardiovascular outcomes, largely reflecting the TRAVERSE trial, which found that testosterone did not raise the rate of major cardiac events versus placebo in higher-risk men. Second, the FDA added a new warning that testosterone can increase blood pressure, so blood pressure should be monitored during therapy. Just as important, the label kept its “limitation of use”: testosterone remains approved only for men with low levels caused by an associated medical condition, and it is not indicated for low testosterone due to normal aging. The takeaway is not “testosterone is now proven safe for everyone” — it is that the cardiovascular picture is more reassuring than the old warning implied, while new monitoring (blood pressure) applies and the appropriate-use rules are unchanged.
When to See a Doctor
Persistent symptoms over several months — especially loss of libido, erectile dysfunction, fatigue, mood changes, or reduced exercise tolerance — warrant evaluation. Men in their 40s and 50s with a classic symptom cluster should have a structured workup rather than starting therapy through a wellness clinic without confirmed, repeated low morning testosterone. New symptoms appearing alongside other concerns (weight gain, snoring, urinary symptoms, low mood) often point to broader conditions that deserve their own evaluation. For overlapping concerns, see erectile dysfunction, low libido in men, and the medical conditions hub.
Frequently Asked Questions
Is andropause a real medical condition?
“Andropause” and “male menopause” are informal terms, not diagnoses. The medical equivalent — late-onset hypogonadism — is a recognized condition with specific biochemical and symptom criteria. Not every middle-aged man with fatigue or low libido qualifies, but a meaningful subset does and can benefit from treatment once the diagnosis is confirmed.
At what age does andropause typically start?
Symptomatic late-onset hypogonadism is uncommon before age 40 and becomes more frequent thereafter. The Urology Care Foundation notes that the share of men meeting criteria for testosterone deficiency rises with age, though prevalence figures in older men reflect measurement methods and include men without symptoms. Age raises the probability but never makes the diagnosis on its own.
Can I treat andropause without TRT?
Often, yes. Weight loss, treating sleep apnea, cutting back on alcohol, and resistance training raise the body’s own testosterone in men with functional hypogonadism. Treating coexisting depression and improving sleep can improve symptoms even without any change in hormone levels. TRT is reserved for men whose deficiency persists after these measures or whose symptoms are severe, and it is always prescriber-supervised.
Does every man go through andropause?
No. Many men retain normal testosterone levels and sexual function well into their 70s and 80s without any specific intervention. The pattern of decline is variable, and lifestyle plays a larger role than is widely appreciated. This is a key difference from female menopause, which is essentially universal.
Is testosterone therapy safe for my heart now that the FDA removed the warning?
The 2025 removal of the cardiovascular boxed warning reflects reassuring trial data, but it does not mean testosterone is risk-free or right for everyone. The label now warns that testosterone can raise blood pressure, and therapy still requires monitoring. Whether TRT is appropriate for you is a decision to make with a clinician who has confirmed low testosterone and reviewed your individual heart, prostate, and fertility considerations.
The Bottom Line
Andropause is a useful shorthand for a real but variable phenomenon — age-related testosterone decline accompanied by symptoms that can affect quality of life. It is not the male equivalent of menopause, and it is not a diagnosis you can make from age and a hunch. Many cases are partially or fully reversible with lifestyle change. Cases that persist after lifestyle correction can benefit from carefully managed, monitored testosterone therapy that is prescribed for a confirmed medical reason — not for normal aging. Distinguishing genuine hypogonadism from depression, sleep apnea, or simple deconditioning is the central task, and it calls for a structured medical evaluation rather than self-diagnosis.
TL;DR: “Andropause” and “male menopause” are popular labels, not a clinical diagnosis. The real, clinician-evaluated condition is late-onset (age-related) hypogonadism, which needs two low morning testosterone tests plus matching symptoms — sexual symptoms are the most telling. Try the reversible fixes first (weight loss, treat sleep apnea, less alcohol, resistance training). Testosterone therapy is prescriber-supervised and monitored, not for normal aging; in 2025 the FDA dropped the cardiovascular boxed warning and added a blood-pressure warning. See a clinician before acting.
This article is for general education and is not medical advice. It does not replace evaluation, diagnosis, or treatment by a qualified clinician. Do not start, stop, or adjust testosterone or any medication on your own. Individual circumstances vary, so discuss your symptoms and any treatment with your own healthcare provider.